A Smartphone-Based Application to Assist Insulin Titration in Patients Undergoing Basal Insulin-Supported Oral Antidiabetic Treatment
Authors' conclusion
The titration app seems to have a positive impact on BOT patients' FBG and HbA1c target achievement and was highly appreciated by both physicians and patients alike.
Study context
- Population
- Physicians (diabetologists, general practitioners, internists) and patients with T2D receiving or starting basal insulin-supported oral therapy (BOT) using the INSULIA insulin-titration app, Germany10 physicians · 34 patients
- Outcome
- Assessment of the app's features, handling and impact on diabetes treatment and self-management
Methodological detailsquestionnaire-based, Questionnaires completed December 2018–June 2019
- Questionnaire-based
- Questionnaires completed December 2018–June 2019
Main finding
As reported in the abstract
- Physicians perceived app-using patients as more involved and more confident in managing insulin therapy than patients not using the app
- Most patients considered the app a tool that assists with safer insulin treatment
- Physicians perceived fasting blood glucose (FBG) and HbA1c targets achieved more often than in patients not using the app
- Physicians perceived the number and severity of hypoglycemic episodes reduced with app use
Observational data: associations, not effects.
Original publication
A Smartphone-Based Application to Assist Insulin Titration in Patients Undergoing Basal Insulin-Supported Oral Antidiabetic Treatment. J Diabetes Sci Technol. Published 30 April 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →